Amol Soin
Technik-/Wissenschafts-/F&E-Leiter bei JANONE INC.
Vermögen: 308 000 $ am 31.05.2024
Aktive Positionen von Amol Soin
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
JANONE INC. | Technik-/Wissenschafts-/F&E-Leiter | 29.01.2020 | - |
TheraVasc, Inc.
TheraVasc, Inc. Pharmaceuticals: MajorHealth Technology TheraVasc, Inc. operates as a pharmaceutical company. It develops treatments for various chronic medical diseases and drugs for unserved vascular disease markets. The company was founded by Anthony Giordano, Christopher Kevil and James Douglas Boudreaux in 2008 and is headquartered in Cleveland, OH. | Direktor/Vorstandsmitglied | - | - |
Technik-/Wissenschafts-/F&E-Leiter | - | - | |
Ohio Pain Clinic | Vorsitzender | - | - |
Gründer | - | - | |
Technik-/Wissenschafts-/F&E-Leiter | - | - | |
Soin Neuroscience, Inc.
Soin Neuroscience, Inc. Medical SpecialtiesHealth Technology Soin Neuroscience, Inc. is a biotech company that specializes in non-opioid based pain management therapies. SNI is based in Dayton, OH and has recently started a medical device division, with several neuromodulation technologies in development. SNI is also working on machine learning and AI-based technologies to help augment physician decision making to make precision medicine possible. However, their sacral nerve stimulation device and spinal cord stimulation device are not approved for use in humans and are currently in early testing phases. The private company was founded by Amol Soin, MD, who has been the CEO since incorporation. | Vorstandsvorsitzender | - | - |
Gründer | - | - | |
Soin Therapeutics LLC
Soin Therapeutics LLC Pharmaceuticals: MajorHealth Technology Part of JanOne, Inc., Soin Therapeutics LLC is a biotechnology company based in Dayton, OH. The company has developed multiple different drugs to treat several chronic conditions, with its lead product being a novel proprietary formulation of low dose naltrexone to treat complex regional pain syndrome (CRPS). Soin Therapeutics has received an orphan drug designation from the FDA for their lead product and is planning to commence a large national late-stage efficacy trial in 2022 of their lead product in CRPS patients. The company was founded by Amol Soin, who has been the CEO since incorporation. Soin Therapeutics was acquired by JanOne, Inc. on December 28, 2022 for $30 million. | Vorstandsvorsitzender | - | - |
Gründer | - | - |
Karriereverlauf von Amol Soin
Ehemalige bekannte Positionen von Amol Soin
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
TriState Pain Society | Präsident | - | - |
Physician Investment Group LLC
Physician Investment Group LLC Financial ConglomeratesFinance Physician Investment Group LLC provides investment services. The private company is based in Dayton, OH. The company was founded by Amol Soin. | Gründer | - | - |
American Society of Interventional Pain Physicians, Inc.
American Society of Interventional Pain Physicians, Inc. Miscellaneous Commercial ServicesCommercial Services American Society of Interventional Pain Physicians, Inc. is an association that provides ambulatory and pain management services. The private company is based in Paducah. | Präsident | - | - |
Society of Interventional Pain Management Surgery Centers | Präsident | - | - |
░░░ ░░░░ ░░░░░░░ ░░ ░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░ | ░░░░░░░░░ | - | - |
Ausbildung von Amol Soin
Brown University | Graduate Degree |
University of Akron | Undergraduate Degree |
University of Tennessee | Masters Business Admin |
Northeast Ohio Medical University | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 15 |
Operativ
President | 4 |
Founder | 4 |
Chief Tech/Sci/R&D Officer | 3 |
Sektoral
Consumer Services | 5 |
Health Technology | 4 |
Industrial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
JANONE INC. | Industrial Services |
Private Unternehmen | 9 |
---|---|
TheraVasc, Inc.
TheraVasc, Inc. Pharmaceuticals: MajorHealth Technology TheraVasc, Inc. operates as a pharmaceutical company. It develops treatments for various chronic medical diseases and drugs for unserved vascular disease markets. The company was founded by Anthony Giordano, Christopher Kevil and James Douglas Boudreaux in 2008 and is headquartered in Cleveland, OH. | Health Technology |
Physician Investment Group LLC
Physician Investment Group LLC Financial ConglomeratesFinance Physician Investment Group LLC provides investment services. The private company is based in Dayton, OH. The company was founded by Amol Soin. | Finance |
Ohio Pain Clinic | |
American Society of Interventional Pain Physicians, Inc.
American Society of Interventional Pain Physicians, Inc. Miscellaneous Commercial ServicesCommercial Services American Society of Interventional Pain Physicians, Inc. is an association that provides ambulatory and pain management services. The private company is based in Paducah. | Commercial Services |
Soin Neuroscience, Inc.
Soin Neuroscience, Inc. Medical SpecialtiesHealth Technology Soin Neuroscience, Inc. is a biotech company that specializes in non-opioid based pain management therapies. SNI is based in Dayton, OH and has recently started a medical device division, with several neuromodulation technologies in development. SNI is also working on machine learning and AI-based technologies to help augment physician decision making to make precision medicine possible. However, their sacral nerve stimulation device and spinal cord stimulation device are not approved for use in humans and are currently in early testing phases. The private company was founded by Amol Soin, MD, who has been the CEO since incorporation. | Health Technology |
The Ohio Society of Interventional Pain Physicians | |
Society of Interventional Pain Management Surgery Centers | |
TriState Pain Society | |
Soin Therapeutics LLC
Soin Therapeutics LLC Pharmaceuticals: MajorHealth Technology Part of JanOne, Inc., Soin Therapeutics LLC is a biotechnology company based in Dayton, OH. The company has developed multiple different drugs to treat several chronic conditions, with its lead product being a novel proprietary formulation of low dose naltrexone to treat complex regional pain syndrome (CRPS). Soin Therapeutics has received an orphan drug designation from the FDA for their lead product and is planning to commence a large national late-stage efficacy trial in 2022 of their lead product in CRPS patients. The company was founded by Amol Soin, who has been the CEO since incorporation. Soin Therapeutics was acquired by JanOne, Inc. on December 28, 2022 for $30 million. | Health Technology |